These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5379566)

  • 21. Mechanism of inhibition of histidine decarboxylase (Clostridium welchii) by 4-bromo-3-hydroxybenzyloxamine and amino-oxyacetic acid.
    Perkinson EN; DaVanzo JP
    Biochem Pharmacol; 1968 Dec; 17(12):2498-501. PubMed ID: 4305306
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of tissue histamine formation by decaborane.
    Medina MA; Landez JH; Foster LL
    J Pharmacol Exp Ther; 1969 Sep; 169(1):132-7. PubMed ID: 5804607
    [No Abstract]   [Full Text] [Related]  

  • 23. Histidine decarboxylase in mouse foetal tissues. II. Physiological role of the enzyme in delivery.
    Maslinski C; Niedzielski A
    Eur J Pharmacol; 1969 Jan; 5(2):196-202. PubMed ID: 5781972
    [No Abstract]   [Full Text] [Related]  

  • 24. Specificity in enzyme inhibition. 1. Synthesis of 4-(4-imidazolyl)-3-amino-2-butanone, 4-(4-imidazolyl)-3-acetamido-2-butanone, and 4-(4-imidazolylmethyl)-2,5-dimethyloxazole for assay as inhibitors of histidine decarboxylase.
    Smissman EE; Weis JA
    J Med Chem; 1971 Oct; 14(10):945-7. PubMed ID: 5115692
    [No Abstract]   [Full Text] [Related]  

  • 25. Properties and regional distribution of histidine decarboxylase in rat brain.
    Schwartz JC; Lampart C; Rose C
    J Neurochem; 1970 Nov; 17(11):1527-34. PubMed ID: 5474655
    [No Abstract]   [Full Text] [Related]  

  • 26. Syntheses of ornithine decarboxylase inhibitors: D- and DL-alpha-hydrazinoornithine.
    Sawayama T; Kinugasa H; Nishimura H
    Chem Pharm Bull (Tokyo); 1976 Feb; 24(2):326-9. PubMed ID: 1260957
    [No Abstract]   [Full Text] [Related]  

  • 27. [New derivatives with presumed histidine decarboxylase inhibitory action].
    Giannini M; Fedi M
    Boll Chim Farm; 1970 Jan; 109(1):39-47. PubMed ID: 4393826
    [No Abstract]   [Full Text] [Related]  

  • 28. Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition.
    Carlsson A; Lindqvist M
    J Pharm Pharmacol; 1970 Sep; 22(9):726-7. PubMed ID: 4394774
    [No Abstract]   [Full Text] [Related]  

  • 29. [Differential action of 2,3,4-trihydroxybenzylhydrazine on amino acid decarboxylases].
    Gonnard P; Duhault J; Nguyen-Philippon C
    Enzymologia; 1967 Mar; 32(3):182-8. PubMed ID: 4914274
    [No Abstract]   [Full Text] [Related]  

  • 30. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
    Gaillard JM; Schaeppi R; Tissot R
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
    [No Abstract]   [Full Text] [Related]  

  • 31. Assay of histidine decarboxylase inhibitors in human plasma.
    Wustrack KO; Levine RJ
    Biochem Pharmacol; 1969 Oct; 18(10):2465-71. PubMed ID: 5403984
    [No Abstract]   [Full Text] [Related]  

  • 32. Histamine formation in rat brain in vivo: effects of histidine loads.
    Schwartz JC; Lampart C; Rose C
    J Neurochem; 1972 Mar; 19(3):801-10. PubMed ID: 5030985
    [No Abstract]   [Full Text] [Related]  

  • 33. 2-hydroxy-5-carbomethoxybenzyloxyamine: a new potent inhibitor of histidine decarboxylase.
    Huszti Z; Kasztreiner E; Kürti M; Fekete M; Borsy J
    Biochem Pharmacol; 1973 Sep; 22(18):2253-65. PubMed ID: 4200282
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of seasonal variation on benzene potentiation of rabbit kidney histidine decarboxylase.
    Cowan A; Waton NG
    Res Commun Chem Pathol Pharmacol; 1975 Mar; 10(3):585-8. PubMed ID: 1135522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of direct correlation between high rate of histamine formation and protein synthesis in fetal rat liver.
    Grahn B
    J Biochem; 1972 Mar; 71(3):519-29. PubMed ID: 5033875
    [No Abstract]   [Full Text] [Related]  

  • 36. Pyridoxal-5'-phosphate as a cofactor for rat brain histidine decarboxylase.
    Palacios JM; Mengod G; Grau M; Picatoste F; Blanco I
    J Neurochem; 1978 Jan; 30(1):213-6. PubMed ID: 413882
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibitory effect of hydrazines on brain decarboxylases.
    de Ropp RS; Furst A
    Proc West Pharmacol Soc; 1967; 10():23-5. PubMed ID: 6055497
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacology of hydrazinocarbonic acids, hydrazinopeptides and various hydrazine derivatives. 3. Inhibition of glutamic acid decarboxylase of the rat brain in vitro and relations to the kinetics of hydrazone formation].
    Oehme P; Schwarz C; Jung F
    Acta Biol Med Ger; 1969; 22(2):359-67. PubMed ID: 5363915
    [No Abstract]   [Full Text] [Related]  

  • 39. Some properties of guinea pig brain glutamate decarboxylase and its inhibition by the convulsant allylglycine (2-amino-4-pentenoic acid).
    Fisher SK; Davies WE
    J Neurochem; 1974 Aug; 23(2):427-33. PubMed ID: 4153560
    [No Abstract]   [Full Text] [Related]  

  • 40. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
    Bartholini G; Da Prada M; Pletscher A
    J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.